Patient-derived xenograft (PDX) models have revolutionized preclinical research in oncology, providing a more clinically relevant platform for testing new therapies. Across different regions, the Asia-Pacific Patient Derived Xenograft Model Market has witnessed substantial growth owing to the increasing prevalence of cancer and the growing demand for personalized medicine. Countries like China,...
English
Arabic
Français
Español
Português
Deutsch
Türkçe
Italiano
Russian
Romaian